Physiotherapy Treatment in Women With Dyspareunia Following Gynecological Cancer: a Pilot Study
Launched by UNIVERSITÉ DE SHERBROOKE · Apr 30, 2019
Trial Information
Current as of May 12, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • History of gynecological cancer (endometrial, cervical, vaginal or other parts of the uterus)
- • Scheduled oncological treatments completed with no signs of cancer for at least 3 months
- • Vulvovaginal pain during sexual intercourse for at least 3 months
- Exclusion Criteria:
- • Vulvovaginal pain before cancer and not related to sexual intercourse
- • Medication recognized to affect pain
- • Refuse to stop other treatments until post-treatment assessment
- • Other conditions interfering with assessment
About Université De Sherbrooke
The Université de Sherbrooke is a leading research institution in Canada, renowned for its commitment to advancing knowledge and innovation in various fields, including health sciences. With a focus on interdisciplinary collaboration, the university actively engages in clinical trials to explore new therapeutic interventions and improve patient care. Its research team comprises experienced professionals dedicated to ensuring the highest ethical standards and scientific rigor in clinical research. The Université de Sherbrooke strives to translate research findings into practical solutions that enhance health outcomes and contribute to the advancement of medical science.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Sherbrooke, Quebec, Canada
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials